Ingenus Pharmaceuticals Revenue and Competitors

Orlando, FL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ingenus Pharmaceuticals's estimated annual revenue is currently $41.8M per year.(i)
  • Ingenus Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Ingenus Pharmaceuticals has 208 Employees.(i)
  • Ingenus Pharmaceuticals grew their employee count by 9% last year.

Ingenus Pharmaceuticals's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Associate VP, Compliance and Commercial OperationsReveal Email/Phone
3
Global VP ARDReveal Email/Phone
4
VP - OperationsReveal Email/Phone
5
VP, Sales & MarketingReveal Email/Phone
6
SVP Acute Care Business Development National Accounts and ContractingReveal Email/Phone
7
VP Commercial OperationsReveal Email/Phone
8
Quality Director and QPReveal Email/Phone
9
Site Quality Director and Technical ResponsibleReveal Email/Phone
10
Director, National AccountsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.5M132N/AN/AN/A
#2
$10.1M5014%N/AN/A
#3
$282.6M1406N/AN/AN/A
#4
$13.9M6944%N/AN/A
#5
$11.3M564%N/AN/A
#6
$11.5M57-7%N/AN/A
#7
$211.7M10724%N/AN/A
#8
$24.1M1205%N/AN/A
#9
$7.8M39-2%N/AN/A
#10
$12.9M64-2%N/AN/A
Add Company

What Is Ingenus Pharmaceuticals?

Ingenus Pharmaceuticals is an emerging privately held U.S. based generic pharmaceutical company with manufacturing and research and development facilities in the U.S.,Switzerland, and India. Since 2010, Ingenus has been developing, manufacturing and commercializing quality generic medications as cost effective solutions for patients and suppliers. With over 65 filings covering a wide range of therapeutic classes ,including transdermal, parenteral, semi-solids, injectable, and extended release products Ingenus is well positioned to becoming a leader in the generic pharmaceutical industry.

keywords:Healthcare,Medical Devices,Pharmaceuticals

N/A

Total Funding

208

Number of Employees

$41.8M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ingenus Pharmaceuticals News

2022-04-19 - Global Semi-solid Dosage Market 2022-2028 Industry ...

Ingenus Pharmaceuticals; Sun Pharmaceuticals; Crescita Therapeutics; Mylan N.V.; Encore Dermatology; LEO Pharma; Almirall, S.A; Aclaris Therapeutics; Taro...

2022-04-17 - Idiopathic Intracranial Hypertension Treatment Market Size ...

Avkare, FDC, Heritage Pharmaceuticals Inc, Ingenus Pharmaceuticals, Janssen – Cilag Pharmaceuticals SA, Lannett Company, Medtronic,...

2022-04-17 - Xanthine Market Size, Outlook And Forecast | Mylan, Watson ...

Mylan, Watson Pharmaceutical, DSM Pharmaceuticals, Ingenus Pharmaceuticals, ... LG Life Sciences, Ardea Biosciences, Teijin Pharma, Mylan.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$66.4M2085%N/A
#2
$34.5M2099%N/A
#3
$62.1M2095%N/A
#4
$50.1M2179%N/A
#5
$33.4M21710%N/A